CARDIAC POSITRON EMISSION TOMOGRAPHY TO QUANTIFY ABNORMAL CORONARY FLOW RESERVE AND RISK STRATIFY A PROSPECTIVE COHORT OF END STAGE RENAL DISEASE PATIENTS

Abstract

Cardiovascular disease is the leading cause of death in end stage renal disease (ESRD) patients and often goes undetected. Abnormal coronary flow reserve (CFR) may demonstrate increased risk in ESRD patients without other evidence of coronary artery disease (CAD). We prospectively studied 131